166 related articles for article (PubMed ID: 12775980)
21. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
[TBL] [Abstract][Full Text] [Related]
22. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
Heinisch G; Barth J
Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
[TBL] [Abstract][Full Text] [Related]
23. Melanin bleaching in argyrophilic staining of AgNORs in pigmented lesions: a morphometric evaluation.
Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Jun; 24(3):166-72. PubMed ID: 12102129
[TBL] [Abstract][Full Text] [Related]
24. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
25. Nucleolar organizer regions in iris nevi and melanomas.
Marcus DM; Mawn LA; Egan KM; Albert DM
Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
[TBL] [Abstract][Full Text] [Related]
26. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
[TBL] [Abstract][Full Text] [Related]
27. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
Pfau A; Eckert F; Schröpfer T; Rüschoff J
Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
[TBL] [Abstract][Full Text] [Related]
28. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
Fallowfield ME; Cook MG
Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
[TBL] [Abstract][Full Text] [Related]
29. Value of argyrophilic nucleolar organizing region protein determinations in nondiagnostic fine needle aspiration samples (due to insufficient cell groups) of thyroid nodules.
Eröz R; Unluhizarci K; Cucer N; Ozturk F
Anal Quant Cytopathol Histpathol; 2013 Aug; 35(4):226-31. PubMed ID: 24341126
[TBL] [Abstract][Full Text] [Related]
30. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis.
Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
32. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
33. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
Rebora A
Dermatology; 1992; 185(3):166-8. PubMed ID: 1446080
[TBL] [Abstract][Full Text] [Related]
34. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
Chen M; Lee JC; Lo S; Shen J
Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
[TBL] [Abstract][Full Text] [Related]
35. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
Wolanski KD; Whitaker D; Shilkin KB; Henderson DW
Cancer; 1998 Feb; 82(3):583-90. PubMed ID: 9452278
[TBL] [Abstract][Full Text] [Related]
36. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
Orrell JM; Evans AT; Grant A
J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
[TBL] [Abstract][Full Text] [Related]
37. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
Fogt F; Vortmeyer AO; Tahan SR
Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
[TBL] [Abstract][Full Text] [Related]
38. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
39. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
Mohanty SK; Dey P; Rana P
Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
[TBL] [Abstract][Full Text] [Related]
40. AgNOR counts in conjunctival malignant melanoma lack prognostic value.
Paridaens AD; Seregard S; Minassian D; Hungerford JL; McCartney AC
Br J Ophthalmol; 1992 Oct; 76(10):621-3. PubMed ID: 1420045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]